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Abnormal Savda Munziq (ASMq) is a traditional Uighur medicinal herbal preparation, commonly used for the treatment and
prevention of cancer. We tested the eﬀects of ethanol extract of ASMq on cultured human hepatoma cells (HepG2) to explore the
mechanism of its putative anticancer properties, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide,
neutral red and lactate dehydrogenase (LDH) leakage assays, testing the incorporation of 3[H]-leucine and 3[H]-nucleosides into
protein, DNA and RNA, and quantifying the formation of malondialdehyde-thiobarbituric acid (MDA) adducts. ASMq ethanol
extract signiﬁcantly inhibited the growth of HepG2 and cell viability, increased the leakage of LDH after 48 hours or 72 hours
treatment, in a concentration- and time-dependent manner (P < .05). Cellular protein, DNA and RNA synthesis were inhibited in
a concentration- and time-dependent manner (P < .05). No signiﬁcant MDA release in culture medium and no lipid peroxidation
in cells were observed. The results suggest that the cytotoxic eﬀects of ASMq ethanol extract might be related to inhibition of
cancer cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis.
1.Introduction
The therapeutic utilization of plants is part of universal
human culture, and products derived from plants are
frequently used for the treatment or prevention of diseases.
Plants, vegetables, herbs and spices used in folk and tradi-
tional medicine are one of the sources of cancer drug discov-
ery and development [1]. A major group of these products
include pigments, vitamins, phenolic lactones, ﬂavonoids,
tannins and alkaloids [2, 3]. Although the mechanism
underlying their anticancer eﬀects is often still unclear, the
fact that the consumption of fruits, vegetables and some
traditional herbal preparations could lower the incidence of
carcinogenesis at a wide variety of sites is broadly supported
[4, 5]. The vinca alkaloids and taxane diterpenes are
examples of successful plant-derived anticancer agents [6].
In the last few years, several other herbal products capable
of anticancer eﬀects have been identiﬁed, the anticancer
properties of which are related to the regulation of cancer-
related gene express, induction of apoptosis, cell cycle arrest
and/or DNA fragmentation as well as inhibition of diﬀerent
cellular enzymes [7–11].
Traditional Uighur medicine, one of the main medical
system in Central Asia, is based on four humors: ﬁre, air,
water and earth, which generate four body ﬂuids: Kan
(blood), Belghem (phlegm), Sapra (yellow bile) and Savda
(black bile). Unbalanced body ﬂuids will cause diseases, and
traditional Uighur formulations will regulate the balance
of body ﬂuids and cure the disease [12]. Abnormal Savda
Munziq (ASMq), a herbal formulation of traditional Uighur
medicine, is widely used in the Xinjiang region of China,
and especially for the treatment and prevention of cancer,
diabetes, cardiovascular disorders as well as chronic asthma.
Its anticancer properties are usually applied by Uighur2 Evidence-Based Complementary and Alternative Medicine
physicians to the treatment and prevention of digestive
cancers. For liver, stomach and colon cancers, the recom-
mended dose is 500mL three times a day. The putative
mechanism of the anticancer eﬀect is still unclear and needs
further investigation. In a previous study, we found that
ASMq aqueous extract had scavenging eﬀects to various
reactive oxygen species (ROS), and could protect against
OH-induced mitochondrial and DNA oxidative damage in
vitro [13–16].
In this article, we carried out experimental studies on
ASMq ethanol extract on cultured HepG2 cells to elucidate
the initial molecular mechanisms responsible for its anti-
cancer eﬀects.
2. Methods
2.1. Chemicals Reagents. Dulbecco’s modiﬁed Eagle medium
(DMEM), fetal calf serum (FCS), ethylene diamine tetra-
acetic acid (EDTA), phosphate-buﬀered saline (PBS), N-
lauroyl sarcosine (N-LS), ribonuclease A (RNase A), pro-
teinase K, ethidium bromide, trypsine-0.02% EDTA mixture
were from Sigma-Aldrich (Lyon, France). 3[H]-leucine,
3[H]-thymidine and 3[H]-uridine were from Perkin Elmer
Life Sciences Inc. (Boston, MA, USA). All other chemicals
used were of analytical grade.
2.2. Preparation of Ethanol Extract of ASMq. ASMq consists
of powdered material of the 10 plants described in Table 1
[17]. The formulation is prepared according to a proprietary
preparation [18]. A voucher of each plant is stored in the
herbarium of Xinjiang Institute of Ecology and Geography,
Chinese Academy of Science. Plant materials were purchased
from Xinjiang Hospital of Traditional Uighur Medicine.
Powdered material (7.8kg) was macerated in ethanol
95% [1:10 (w/v)] at room temperature for 4 hours with
continuous stirring. The maceration was repeated three
times (4 hours). After evaporation, the residue was extracted
by petroleum ether. The remaining water fraction was
concentrated to dryness under reduced pressure and low
temperature on a rotary evaporator. Extract yield of plant
material was 935g (12%) (w/w). Extract was dissolved in
distilled water (100mgmL−1)a n dk e p ta t−20◦Cp r i o rt o
utilization. The other concentrations used in the experiment
were prepared by addition of cell culture medium (DMEM).
2.3. Cell Lines and Culture Medium. Human hepatoma
adherent cell lines (HepG2) were obtained from the Amer-
ican Type Culture Collection (ATCC). Cells were cultured
and maintained with DMEM supplemented with 10% FCS,
2% l-glutamine (200mM) and 1% penicillin-streptomycin
(100U to 100mgmL−1) in a humidiﬁed 5% CO2–95% air
mixture at 37◦C.
2.4. MTT Assay. Cell viability was determined using MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] assay. Cells were seeded in 96-well microplates (5000
cells/well/200mL) and routinely cultured in a humidiﬁed
incubator for 24 hours. Cell culture mediums were removed
with a pipette and herbal extracts were added in serial
concentrations (ranging from 0.05 to 10mgmL−1)a n dr e -
incubated for 72 hours. We also tested a control group
(DMEM without herbal extract), a blank group (without
cells or medium). The medium with or without herbal
extract was then discarded, and 100mL of MTT solution
(0.5mgmL−1 in DMEM) was added to every well and
re-incubated for an additional 2 hours. One hundred
microliters of 10% SDS, 0.01MHCl solution was added to
each well to dissolve the formazon crystals formed. The
p l a t e sw e r et h e nr e a do nam i c r o p l a t er e a d e r( D Y N A T E C H
MR 4000, France) at 560nm. In this test, four wells were
used for each concentration of ASMq, and ﬁve independent
experiments were performed.
2.5. Neutral Red Uptake Assay. Cells were seeded in 96-well
microplates (10000 cells/well/200mL), routinely cultured in
a humidiﬁed incubator for 24 hours. Cells were maintained
in culture and exposed to ASMq ethanol extract over a range
of concentrations (0.5–7.5mgmL−1) .A f t e r4 8h o u r se x p o -
sure to ASMq, neutral red (NR) uptake test was performed
according to the procedure described by Creppy [19]. Brieﬂy,
at the end of the treatment, the medium with or without
ASMq was discarded and 200µL of freshly prepared neutral
red solution (50µgmL −1) was added to every well and re-
incubated for an additional 4 hours at 37◦C. Thereafter,
the cells were carefully washed twice with 200µL of PBS
to eliminate extracellular NR. The incorporated dye was
eluted from the cells by adding 200µL elution medium (50%
ethanol supplemented with 1% acetic acid, v/v) into each
wellfollowedbygentleshakingofmicroplatefor15min.The
plates were then read at 540nm using a microplate reader
(DYNATECH MR 4000, France). The number of cells in
the presence of ASMq was compared to that observed in
control cultures and the percentage of viable cells calculated.
The IC50 is determined and expressed as microgram per
milliliter.
2.6. Lactate Dehydrogenase Leakage Assay. HepG2 cells (1 ×
105 cells mL−1well−1) were pre-incubated in 24-well multi-
dishes for 24 hours at 5% CO2–95% air 37◦C. Cell viability
was assessed by lactate dehydrogenase (LDH) leakage trough
the membrane into the medium. Aliquots of the cell culture
supernatants from control and serial concentration of ASMq
ethanol extract treated cultures were tested after 48 or 72
hours incubation for the presence of LDH using a LDH
assay kit (Biomerieux, France). In this test, three wells were
usedforeachconcentrationofASMq,andthreeindependent
experiments were performed.
2.7. Cellular Protein, DNA and RNA Synthesis Assay. HepG2
cells (2.5 × 105 cells/mL/well) were cultured in 24-well
multidishes for 48 hours at 37◦C. Five concentrations
ranging from 0.5 to 7.5mgmL−1 of extract were used. The
control cultures were prepared by adding DMEM without
any addition. Four wells were used for each concentra-
tion, and two independent experiments were performed.
After 24 or 48 hours incubation at 37◦C with or with-
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Table 1: Plants contained in Uighur herbal formula: ASMq.
Latin name Family Part used Uighur name Chinese name
Adiantum capillus-veneris L. Adiantaceae Whole plant Pirsiyavxan Tiexianjue
Alhagi pseudalhagi (Bieb.) Desv. Fabaceae Branch secretion K¨ ok tantak Citang
Anchusa italica Retz. Boraginaceae Whole plant Gavziban Niushecao
Cordia dichotoma G.Forst. Boraginaceae Fruit Serbistan Pobumuguo
Euphorbia humifusa Willd. Euphorbiaceae Whole plant Yalmank¨ ulak Dijincao
Euphorbia maculata L.
Foeniculum vulgare Mill. Apiaceae Fruit Arpabidiyan Xiaohuixiang
Glycyrrhiza uralensis Fisch. ex DC. Fabaceae Radix or rhizoma Q¨ uq¨ uk buya Gancaogen
Glycyrrhiza inﬂata Batalin Fabaceae Radix or rhizoma
Glycyrrhiza glabra L. Fabaceae Radix or rhizoma
Lavandula angustifolia Mill. Lamiaceae Aerial parts ¨ Ustihuddus Xunyicao
Melissa oﬃcinalis L. Lamiaceae Whole plant Badrenjiboye hindi Mifenghua
Ziziphus jujuba Mill. Rhamnaceae Fruit Qilan Dazao
radioactive protein synthesis precursor, 3[H]-leucine (spe-
ciﬁcactivity, 185GBqmmol−1)o r2m C im L −1 of radioactive
DNA synthesis precursor, 3[H]-thymidine (speciﬁc activ-
ity, 3259.76GBqmmol−1)o r2 m C i m L −1 of radioactive
RNA synthesis precursor, 3[H]-uridine (speciﬁc activity,
888GBqmmol−1) was incorporated during a 2.5 hours
pulse.Oncethepulsewasﬁnished,themediumwasremoved
and cells were harvested by trypsinization. After centrifuged
at 600g for 5min at 10◦C, the supernatants were removed
and cell pellets were resuspended by adding 300mL of 20%
NaOH and sonicated for 30 s with Bioblock sonicater at
75mV, and all the samples were incubated for 20min at
37◦C. Twenty microliters of each homogenate was taken
for total protein quantiﬁcation using the Bradford method
[20]. The samples were kept in −20◦C freezer after addition
of 1mL of cold TCA (40%) until ﬁltration. Lastly, the
samples were ﬁltered on 3mm Whatman microﬁber ﬁlter
discs, which were dried at 80◦C for 20min. The radioactivity
on the paper ﬁlters was counted with liquid scintillation
analyzer after addition of 5mL of Beckman Ready Organic
supplemented by 0.9% acetic acid. The c.p.m. values were
adjusted with total protein content in each sample. In this
test, four wells were used for each concentration of ASMq
ethanol extract, and three independent experiments were
performed.
2.8. Extraction and Determination of Malondialdehyde-
Thiobarbituric Acid Adduct. HepG2 (1 × 105 cells/well/mL)
were cultured in 24-well multidishes for 24 hours at 37◦C.
Five concentrations ranging from 0.5 to 7.5mgmL−1 of
ASMq were used. The control cultures were prepared by
adding DMEM without any addition. After incubation with
or without extract, the culture medium was removed. After
rinsing with 0.5mL of fresh-cold PBS twice, cells were col-
lected by trypsinization, centrifuged at 600g for 5min. The
cell pellets were resuspended in 270 µL of STE (0.1MNaCl,
20mM EDTA, 50mM Tris–HCl, pH 8.0), after adding 25µL
of 7% SDS the cells were sonicated for 30s at 75mV, 20mL of
each homogenate was taken for total protein quantiﬁcation
[20].Thecellswerelysedwith20µLofSDS7%(w/v),300µL
of 0.1MHCl, 40µL of phosphotungstic acid 1% (w/v) and
300µL of 0.67% (w/v) thiobarbituric acid. The tubes were
shaken for 1min and incubated at 80◦Cf o r1h o u ri nt h e
dark. They were further placed for 20min in an ice bath
(0◦C). After this period, 300µLo fn-butanol was added and
tubes were shaken vigorously for 1min. After centrifugation
for 10min at 900g at 4◦C, the n-butanol phase from
each sample containing MDA-TBA adduct was separated
and analyzed by high performance liquid chromatography
(HPLC) with ﬂuorometric detection [21].
The HPLC system consisted of a chromatography pump
(Bischoﬀ Chromatography, Germany) equipped with a Shi-
madzu 8450 Fluorescence HPLC Monitor (Japan Spectro-
scopic Co.). Analysis of the malondialdehyde-thiobarbituric
(MDA-TBA) adducts was performed at room temperature
on a Ultrasep C18 column using methanol–water 40:60
(v/v) as the mobile phase adjusted to pH 8.3 by addition
of 1MKOH. The ﬂow rate was maintained at 0.5mL/min.
The excitation and emission wavelengths were 515 and
553nm, respectively. The amount of MDA-TBA measured
was referred to the protein content of cellular homogenates
using the Bradford method [20]. In this test, three wells were
used for each concentration of ASMq, and two independent
experiments were performed. Pic3 software was used for the
analysis of chromatography.
2.9. Statistical Analysis. The data are expressed as mean ±
SD of at least three independent determinations in triplicate
or quadruplicate for each experimental point. The statistical
diﬀerences between treated groups and control groups were
determinedbyStudent’st-test,andthesigniﬁcancethreshold
was set to P < .05.
3. Results
3.1. Inhibition of HepG2 Cell Growth by ASMq Ethanol
Extract. After 72 hours incubation, ASMq ethanol extract
inhibited HepG2 cell growth in a concentration-dependent4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Inhibition of HepG2 cell growth by ASMq ethanol
extract. Cells were treated with diﬀerent concentration of ASMq
ethanol extract (0.05–10mgmL−1)a t3 7 ◦C, 5% CO2 for 72 hours.
CellgrowthwasdeterminedbytheMTTassay.Resultsareexpressed
as mean ± SD of ﬁve independent experiments.
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Figure 2: HepG2 cell viability in the presence of increasing
concentrations of ASMq ethanol extract. Cells were incubated
with diﬀerent concentrations of ASMq aqueous extract (0.5–
7.5mgmL−1)a t3 7 ◦C, 5%CO2 f o r4 8h o u r s .C e l lv i a b i l i t yw a s
determinedbytheneutralredtest.Resultsareexpressedasthemean
± SD of three independent experiments.
manner (Figure 1). ASMq ethanol extract reached its max-
imum inhibitory eﬀect (68.4%) at 2.5mgmL−1 (Figure 1).
The IC50 was determined to be 0.8 ± 0.12mgmL−1.
3.2. Inhibition of HepG2 Cell Viability by ASMq Ethanol
Extract. ASMqethanolextractsigniﬁcantlyinhibitedHepG2
cell viability in a concentration-dependent manner after 48
hours incubation. IC50 was 0.9 ± 0.2mgmL−1 (Figure 2).
3.3.IncreaseofLDHLeakagebyASMqEthanolExtract. There
was a signiﬁcant increase of HepG2 cell membrane LDH
leakage after incubation with serial concentrations of ASMq
ethanol extract (Figure 3). In agreement with the results of
the MTT test and neutral red test, signiﬁcant toxicity was
observed in HepG2 cells with ASMq concentrations from
0.5 to 7.5mgmL−1 a f t e r4 8o r7 2h o u r so ft r e a t m e n t( P
< .05). Concentration dependence was observed at both
48 hours and 72 hours incubation. In addition, ASMq
ethanol extract showed a time-dependent toxicity in our
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Figure 3: Percentage of LDH leakage into the cell culture medium
after incubation of HepG2 cells with ASMq ethanol extract. Results
are expressed as mean ± SD of three independent experiments. aP
< .05 compared with control cultures; bP < .05 compared with 48
hours incubation.
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Figure 4: Inhibition of protein synthesis in HepG2 cells after
incubation with ASMq ethanol extract. Protein synthesis was
evaluated by incorporation of 3[H]-leucine during a 2.5 hours
pulse. Results are expressed as the mean ± SD of three independent
experiments. aP < .05 compared with control culture; bP < .05, 48
hours versus 24 hours treatment with ASMq ethanol extract.
experimental condition with eﬀects greater at 72 hours than
at 48 hours (Figure 3).
3.4. Inhibition of Cellular Synthesis of Protein, DNA and
RNA by ASMq Ethanol Extract. There was a concentration-
dependent inhibition of protein synthesis after 24 hours
incubation. After 48 hours, the inhibition no longer was
dose-dependent over the range of doses tested, but seemed
stable around 43–52%. Inhibition was signiﬁcantly greater
at 48 than at 24 hours for all concentrations (P < .05)
(Figure 4).Evidence-Based Complementary and Alternative Medicine 5
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Figure 5: Inhibition of DNA synthesis in HepG2 cells after incu-
bation with ASMq ethanol extract. DNA synthesis was evaluated by
incorporation of 3[H]-thymidine during a 2.5 hours pulse. Results
are expressed as the mean ± SD of three independent experiments.
aP < .05 compared with control culture; bP < .05, 48 hours versus
24 hours treatment with ASMq.
Increasing concentrations of ASMq ethanol extract from
0.5 to 7.5mg/mL dose-dependently inhibited cellular DNA
synthesis from 8.3 to 35.4% at 24 hours, from 15.5% to
48.5% at 48 hours (Figure 5). Inhibition was greater after 48
hours than after 24 hours incubation.
Synthesis of RNA in HepG2 cells was inhibited in a
concentration-dependent manner from 14.7% to 46.4% and
26.0% to 55.7% at 24 hours and 48 hours, respectively
(Figure 6). There was no clear time-dependent increase in
this inhibition.
3.5. Lipid Peroxidation of HepG2 Cells by ASMq Ethanol
Extract. There was no signiﬁcant MDA release in culture
medium and no lipid peroxidation compared to controls,
even at the highest concentration (10, 20 or 50mgmL−1)
(datanotshown).Thisresultisinaccordancewithaprevious
study showing ASMq had scavenging eﬀects on reactive
oxygen species [14].
4. Discussion
ASMq, used for the treatment and prevention of cancers,
is made from several plants (Table 1). Pharmacological
information that can be related to cancer inhibiting eﬀects
of some of the plants is outlined in Table 2.
Various antioxidative activities involving detoxiﬁcation
such as superoxide anion radical scavenging, inhibition of
hydrogen peroxide, enhancement of superoxide dismutase,
catalase and glutathion peroxidase as well as iron-chelating
activities have been reported for several plants extracts
such as Anchusa italica, Foeniculum vulgare, Glycyrrhiza sp.,
Lavandula angustifolia and Melissa oﬃcinalis.
Anti-inﬂammatory activity has been demonstrated using
chemical-induced writhing test and carrageenan paw edema
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Figure 6: Inhibition of RNA synthesis in HepG2 cells after
incubation with ASMq ethanol extract. RNA synthesis was eval-
uated by incorporation of 3[H]-uridine during a 2.5 hours pulse.
Results were expressed as the mean ± SD from three independent
experiments. aP < .05, compared with control culture; bP < .05
compared with 24 hours treatment of ASMq.
for polyphenolic extract and essential oil of L. angusti-
folia [43]. It is thought that these antioxidant and anti-
inﬂammatory properties are related to the treatment of
cancer.
Findings on licorice have shown in vitro and in vivo
anticancer eﬀects [28, 50]. Glycyrrhetinic acid, constituent
of G. glabra and G. uralensis, developed anti-initiating and
anti-promoting activities [39]. Isoliquiritigenin, one of the
ﬂavonoids of G. glabra, induced apoptosis of MGC-803
cells through calcium and Deltapsi-dependent pathways
[36] as well as cell cycle arrest and cell growth inhibition
[32]. Isoliquiritigenin also activated macrophages and cyto-
toxicity of splenic lymphocytes [33]. Glabrene showed an
estrogen receptor-dependent aﬃnity higher than glabridin
with growth-promoting eﬀect at low concentration and
ER-independent antiproliferative activity at concentrations
above 15mM [37]. Licochalcone-A, phytoestrogen from
G. glabra, decreased the anti-apoptotic protein bcl-2 and
modiﬁed the bcl2-/bax ratio in favor of apoptosis [38].
Beta-hydroxy-DHP from G. Glabra extract induced Bcl-2
phosphorylation, G2/M cell cycle arrest and apoptosis in
breast and prostate tumor cells [34]. Recently, the ethanol
extract of G. uralensis root has been shown to possess anti-
cancer activity through upregulation of tumor suppressor
gene p53, pro-apoptotic protein Bax and p21waf1/cip1 and
downregulationofcdk2andcyclinE.Theextractalsocaused
G1 cell cycle arrest [31]. The antiangiogenic activity of G.
glabra is also a potential supplemental source to eradicate
tumor growth [28].
Other plants have shown interesting results that can sug-
gest their potential uses as antitumoral agents. Essential oils
from L. angustifolia showed strong antimutagenic activity
in Salmonella typhimurium strains exposed to the direct
mutagen 2-nitroﬂuorene [41]. Lavender oil and linalool have
also been demonstrated to be cytotoxic to human skin cells6 Evidence-Based Complementary and Alternative Medicine
Table 2: Pharmacological activities of plants from Uighur formula: ASMq.
Plant Uses Pharmacological properties Reference
Bugloss
Edible in Mediterranean
diet
Radical scavenging, inhibition of H2O2 and Fe2+-chelating activity in
vitro [22]
Stomach ulcer in Middle
East
Protective eﬀect on ethanol-induced gastric ulcer in animals (root
aqueous extract) [23]
Common fennel
Medicinal and aromatic
herb Antioxidant activity of methanolic extract [24]
Edible in Mediterranean
diet Radical scavenging and iron-chelating activity in vitro [22]
Edible in Indian diet Antioxidant activity of aqueous extract (comparison with ascorbic acid) [25]
Digestive medicine Total antioxidant, radical scavenging and metal chelating activities of
aqueous and ethanol extracts [26]
Fragrant
manjack Edible in India Nutritional value: high level of phosphorus [22]
Jujube Aid digestion in China Immunological activities: induced a rat spleen cells proliferation [27]
Licorice
Stomachic and cough
medicine
in vitro and in vivo inhibition of Ehrlich ascites tumor cells proliferation
(G. glabra) [28]
Inhibition of cell proliferation in the MCF-7 breast cancer cell line (G.
uralensis ethanol extract) [29]
Inhibition of H2O2-induced apoptosis of lung ﬁbroblastV79-4 cells (G.
uralensis methanol extract) [30]
Antinephritis activity of licochalcone A (G. inﬂata)[ 31]
Prostate cancer cell growth inhibition of isoliquiritigenin [32]
Suppression of pulmonary metastasis by isoliquiritigenin [33]
Antitumoral eﬀects similar to those of antimicrotubule agents of
beta-hydroxy-DHP (G. glabra) [34]
Inhibition of lipid peroxidation (G. glabra)[ 35]
Isoliquiritigenin induced apoptosis in human gastric cancer MGC-803
cells [36]
Biphasic eﬀect on the growth of breast tumor cell of glabridin and
glabrene [37]
Licochalcone-A from G. glabra induced aptotosis of MCF-7 and HL-60
cell lines [38]
Protect DNA damage and decrease the stimulation of DNA repair
synthesis by glycyrrhetinic acid [39]
Lavender
Folk medicine Antioxidant activity (DPPH) of water extract [40]
Antiseptic uses Strong antimutagenic activity of essential oil (bacterial reverse mutation
assay) [41]
Wound healing Cytotoxicity of essential oil to human skin cells (in vitro)[ 42]
Iranian traditional
medicine Anti-inﬂammatory activity of polyphenolic fraction and essential oil [43]
Turkish folk medicine Neuroprotective eﬀect against glutamate toxicity (aqueous extract) [44]
Inﬂammatory diseases Inhibition of lipid peroxidation (phenolic compounds) [45]
Lemon Balm
Sedative, digestive medicine Antioxidant of the polar fraction (ethanolic extract, decoction) [40]
Folk medicine Antioxidant capacity (FRAP, DPPH, ABTS) of infusion [46]
Mediterranean diet Antioxidant activity (DPPH) of aqueous extract [47]
Bulgarian folk medicine Antioxidant activity (APTS) of infusion [48]
Herbal medicine Oil cytotoxicity on cell lines A549, MCF-7, Caco-2, HL-60, K562 and
B16F10 [49]
Inﬂammatory diseases Inhibition of lipid peroxidation (phenolic compounds) [45]Evidence-Based Complementary and Alternative Medicine 7
in vitro [42]. Oil from M. oﬃcinalis induced cytotoxicity on
human cancer lines (A549, MCF-7, Caco-2, HL-60, K562)
and a mouse cell line B16F10 [49].
Though the herbal remedy tested here has been used
extensively in traditional Uighur medicine, its eﬀects on
cancer cell growth or metabolism had not been tested
previously.
In the present study, we used human hepatoma cells
(HepG2) to examine the cytotoxic eﬀects of ASMq ethanol
extracttoelucidatetheinitialmolecularmechanismsrespon-
sible for these eﬀects. We demonstrated that ASMq ethanol
extract had signiﬁcant cytotoxic eﬀect by reducing the cell
growth rate and cell viability, increasing the extra-cellular
LDH leakage and inhibiting cellular protein, DNA and RNA
synthesis.
Inhibitingcancercellgrowthhasbeenacontinuouseﬀort
in cancer treatment. Most anticancer agents act by reducing
cell growth and inducing cell death through more or less
detailed and complicated pathways. Our results showed that
ASMq ethanol extract inhibits HepG2 cell growth in a
concentration-dependent manner after 72 hours incubation.
Even at a low concentration, there still was a potent inhibitor
eﬀect, the 50% inhibition concentration being determined
to be about 0.8mgmL−1 in our experimental conditions.
This result was conﬁrmed by the neutral red test showing
that ASMq ethanol extract decreased HepG2 cell viabil-
ity in a concentration-dependent manner after 48 hours
incubation.
The most frequently used endpoints in cytotoxicity are
the breakdown of the cellular permeability barrier, measured
by dye exclusion (trypan blue) or by the release of intra-
cellular enzymes like LDH as a consequence of membrane
damage or cell detachment [51]. It is well known that
cellular injury may lead to a complex sequence of changes
to structural and molecular events, frequently culminating
in cell death. Many subcellular structures, such as the plasma
membrane, nucleus, mitochondria, endoplasmic reticulum
and lysosomes are all targets for anticancer agents [52].
The LDH leakage assay is based on the principle that dead
cells lose the ability to maintain their plasma membrane
integrity, permitting intracellular constituents such as LDH
to leak out of the cell into the culture medium. ASMq
ethanol extract induced a signiﬁcant increase in extra-
cellular LDH levels at both 48 hours and 72 hours, in
a concentration-dependent manner. ASMq ethanol extract
also exhibited time-dependent properties on LDH leakage
since the eﬀects at 72 hours were greater than at 48 hours.
ASMq ethanol extract may alter the integrity of HepG2 cell
plasma membranes either directly or as a secondary result
of damage to some other cell component and alter the net
rates of nutrient uptake in the cells. Therefore, the cytotoxic
eﬀects of ASMq ethanol extract might at least in part be
correlated with loss of cell plasma membrane integrity and
potential.
Lipid peroxidation is one of the consequences of
oxidative damage and has been suggested as a general
mechanism for cell injury and death. MDA, the end product
of lipid peroxidation, has been extensively studied and
measured as an index of lipid peroxidation and as a marker
of oxidative stress [53]. Many anticancer agents causing
cell death are known to induce an overproduction of ROS,
and thereby causing oxidative damage to DNA, proteins
and lipids and possibly inducing apoptosis. But in our
experimental conditions ASMq did not induce signiﬁcant
lipid peroxidation in HepG2 cells after 24 or 48 hours. This
indicates that probably the mechanism leading to loss of cell
membrane integrity is not due to ROS, but more probably
to inhibition of lipoproteins in membrane since as shown
above ASMq inhibited protein synthesis.
To explore its eﬀect on cell mechanisms, the eﬀects of
ASMq ethanol extract on some basic cell functions such as
protein, DNA and RNA synthesis were studied showing a
concentration and time-dependent inhibition of DNA and
protein synthesis in cells treated with ASMq ethanol extract
asreﬂectedbyitsinhibitionof3H-thymidineand3H-leucine
uptake. Our results showed that ASMq ethanol extract
obviously decreased DNA and protein synthesis at 24 and
48 hours incubation. For DNA synthesis, the inhibition was
concentration-dependent after 24 and 48 hours incubation,
with also a time-dependent eﬀect, the inhibition being
greater at 48 than at 24 hours for all concentrations, whereas
for protein synthesis the inhibition was maximal from the
ﬁrst concentration at 48 hours. We found dose dependence
for RNA synthesis, but no clear time dependence: there
was no diﬀerence in the inhibition after 24 or 48 hours
incubation. DNA, RNA and protein synthesis are directly
proportional to cellular growth rate [54, 55]. Our results
likely support this viewpoint: the inhibition of cell growth by
ASMq ethanol extract seems closely related to cellular DNA,
RNA and protein synthesis inhibition. Thus, inhibition of
cellular DNA, RNA and protein synthesis might be involved
in the mechanisms of ASMq ethanol extract cytotoxicity
eﬀect.
5. Conclusions
HepG2 cell growth was concentration dependently inhibited
by ASMq ethanol extract. Our ﬁndings suggest that the
cytotoxic eﬀect of ASMq ethanol extract is a combination
of its eﬀects in reduction of HepG2 cell growth, alteration
of cell membrane integrity and inhibition of cellular protein,
DNA and RNA synthesis. As an herbal preparation, ASMq
ethanol extract undoubtedly contains a variety of active
compounds such as alkaloids, polyphenols or terpenoids,
as well as vitamins and fatty acids, which may act on
diﬀerent pathways of cancer cell growth. Further studies will
be needed to identify the active compound(s) that confer
anticancer activities to ASMq ethanol extract. Once such
compounds are identiﬁed, the mechanisms by which they
exert their eﬀects can begin to be characterized.
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